Compare PRZO & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRZO | COSM |
|---|---|---|
| Founded | 2014 | 2009 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Other Pharmaceuticals |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.1M | 16.1M |
| IPO Year | 2023 | 2013 |
| Metric | PRZO | COSM |
|---|---|---|
| Price | $1.27 | $0.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 452.0K | ★ 611.1K |
| Earning Date | 08-28-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,007,440.00 | ★ $59,792,819.00 |
| Revenue This Year | N/A | $28.14 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 80.42 | 6.69 |
| 52 Week Low | $0.53 | $0.28 |
| 52 Week High | $3.16 | $1.32 |
| Indicator | PRZO | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 42.37 | 23.06 |
| Support Level | $1.30 | $0.44 |
| Resistance Level | $1.51 | $0.66 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 3.85 | 6.86 |
ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the company applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.